12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

Cephalon neurology news

Cephalon disclosed in an SEC filing that last month it received a subpoena from the U.S. Postal Service Office of Inspector General requesting documents related to cancer pain drug Fentora fentanyl buccal tablets. The company said the investigation is related...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >